P

    PetMed Express Inc (PETS)

    Official site

    HEALTHCARE • PHARMACEUTICAL RETAILERS • NASDAQ

    $1.89
    +0.01 (+0.53%)

    Market Cap: $40.97M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    38%(15/40)
    Avg Surprise
    -84.34%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.06
    Range$-0.06 - $-0.06
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$0.10+266.7%
    60d ago$0.10+266.7%
    30d ago$0.10+266.7%
    7d ago$0.10+266.7%
    Current$-0.06
    Revenue Consensus
    $0
    Range$0 - $0
    0 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.11
    Range$-0.11 - $-0.11
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$0.00+100.0%
    60d ago$0.00+100.0%
    30d ago$0.00+100.0%
    7d ago$0.00+100.0%
    Current$-0.11
    Revenue Consensus
    $0
    Range$0 - $0
    0 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Mar 27EST
    		-$0.12---
    Dec 26EST
    		-$-0.11---
    Sep 26EST
    		-$-0.06---
    Jun 26
    Reported Jul 27
    		$-0.28$0.12-333.33%Miss-366.7%
    Mar 26
    Reported Jun 2
    		$-0.19$-0.18-5.56%Miss+44.1%
    Dec 25
    Reported Feb 5
    		$-0.50$-0.06-733.33%Miss-1566.7%
    Sep 25
    Reported Dec 19
    		$-0.56$-0.49-14.29%Miss-609.1%
    Jun 25
    Reported Aug 11
    		$-0.06N/A-128.57%Miss-133.3%
    Mar 25
    Reported Jun 9
    		$-0.34$-0.04-750.00%Miss-36.0%
    Dec 24
    Reported Feb 10
    		$-0.03$0.01-400.00%Miss+70.0%
    Sep 24
    Reported Nov 6
    		$0.11$-0.05+320.00%Beat+3335.3%
    Jun 24
    Reported Aug 6
    		$0.18$-0.09+300.00%Beat+80.0%
    Mar 24
    Reported Apr 15
    		$-0.25$-0.07-257.14%Miss+0.0%
    Dec 23
    Reported Feb 8
    		$-0.10$-0.01-900.00%Miss-600.0%
    Sep 23
    Reported Oct 30
    		$-0.00N/A-103.78%Miss-102.0%
    Jun 23
    Reported Jul 31
    		$0.10$0.07+42.86%Beat-33.3%
    Mar 23
    Reported May 22
    		$-0.25$0.14-278.57%Miss-183.3%
    Dec 22
    Reported Feb 6
    		$0.02N/A-88.24%Miss-90.5%
    Sep 22
    Reported Nov 7
    		$0.17$0.26-34.62%Miss-45.2%
    Jun 22
    Reported Jul 25
    		$0.15$0.23-34.78%Miss-34.8%
    Mar 22
    Reported May 9
    		$0.30$0.28+7.14%Beat-11.8%
    Dec 21
    Reported Jan 24
    		$0.21$0.32-34.38%Miss-44.7%
    Sep 21
    Reported Oct 25
    		$0.31$0.35-11.43%Miss-26.2%
    Jun 21
    Reported Jul 26
    		$0.23$0.35-34.29%Miss-41.0%
    Mar 21
    Reported May 3
    		$0.34$0.40-15.00%Miss-2.9%
    Dec 20
    Reported Jan 19
    		$0.38$0.38+0.00%Beat+11.8%
    Sep 20
    Reported Oct 26
    		$0.42$0.40+5.00%Beat+27.3%
    Jun 20
    Reported Jul 20
    		$0.39$0.40-2.50%Miss+50.0%
    Mar 20
    Reported May 4
    		$0.35$0.29+20.69%Beat+9.4%
    Dec 19
    Reported Jan 21
    		$0.34$0.30+13.33%Beat-10.5%
    Sep 19
    Reported Oct 21
    		$0.33$0.26+26.92%Beat-36.5%
    Jun 19
    Reported Jul 22
    		$0.26$0.42-38.10%Miss-58.1%
    Mar 19
    Reported May 6
    		$0.32$0.46-30.43%Miss-36.0%
    Dec 18
    Reported Jan 22
    		$0.38$0.48-20.83%Miss-13.6%
    Sep 18
    Reported Oct 22
    		$0.52$0.50+4.00%Beat+20.9%
    Jun 18
    Reported Jul 23
    		$0.62$0.63-1.59%Miss+37.8%
    Mar 18
    Reported May 7
    		$0.50$0.47+6.38%Beat+35.1%
    Dec 17
    Reported Jan 22
    		$0.44$0.31+41.94%Beat+83.3%
    Sep 17
    Reported Oct 23
    		$0.43$0.30+43.33%Beat+79.2%
    Jun 17
    Reported Jul 24
    		$0.45$0.38+18.42%Beat-
    Mar 17
    Reported May 8
    		$0.37$0.26+42.31%Beat-
    Dec 16
    Reported Jan 23
    		$0.24$0.25-4.00%Miss-
    Sep 16
    Reported Oct 24
    		$0.24$0.27-11.11%Miss-

    Dividends

    Dividend Metrics

    Yield0.00%
    Annual/Share$0.00
    Frequency4
    View PETS's full dividend history

    Key Metrics

    Valuation
    P/E Ratio-1.24EV/EBITDA0.63x
    Price/FCF-1.47xFCF Yield-67.88%
    Profitability
    Profit Margin-17.30%Operating Margin-15.20%
    ROE-78.60%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio0.68xQuick Ratio0.47x
    Trading Statistics
    Beta0.79Avg Volume97.16K
    52-Week High$4.1052-Week Low$1.57

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.80
    SMA 20$1.87
    SMA 50$1.91
    SMA 200$2.38
    EMA 10$1.84
    EMA 20$1.86
    EMA 50$1.92
    EMA 200$2.33

    MACD

    Line: -0.03Signal: -0.04Hist: 0.01

    ADX

    ADX: 20.6+DI: 27.4-DI: 19.6

    Aroon & PSAR

    Aroon Up52.0
    Aroon Down64.0
    PSAR$1.97

    Bollinger Bands

    Upper Band$2.08
    Lower Band$1.67
    %B Position2199%(Upper)
    Band Width0.54

    RSI (14-Day)

    Neutral
    51.6

    Momentum Oscillators

    Stoch %K48.0
    Stoch %D37.6
    Williams %R-47.1
    ROC (10d)8.0%
    Momentum0.14
    CCI (20d)14.1
    MFI (14d)56.5

    Volatility Measures

    ATR (14d)$0.07(3.6%)
    StdDev (20d)0.10
    Hist Vol44.9%(High)

    Volume Flow

    VWAP$1.89
    OBV162.4M
    AD Line-59.2M
    CMF (20d)-0.046

    Volume Metrics

    Avg Vol (20d)99.1K
    Vol Ratio0.6x
    VWMA (20d)$1.87

    Pivot Points

    R3$2.02
    R2$1.97
    R1$1.93
    Pivot Point$1.88
    S1$1.83
    S2$1.78
    S3$1.74

    Advanced Oscillators

    TSI-13.90
    Ultimate Osc52.8
    KST-75.72

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$41.02M$42.82M$40.66M$44.36M$51.18M$50.76M$51.96M$58.04M$66.21M$59.53M$65.32M$71.00M
    Cost of Revenue$29.68M$28.88M$31.20M$31.95M$36.78M$35.56M$35.83M$39.27M$47.17M$35.24M$47.43M$50.94M
    Gross Profit$11.33M$13.94M$9.46M$12.41M$14.40M$15.20M$16.13M$18.77M$19.04M$24.30M$17.88M$20.06M
    Operating Expenses$17.57M$19.63M$19.93M$20.80M$48.53M$21.22M$16.58M$18.22M$14.65M$28.13M$20.96M$19.19M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$11.20M$11.41M$12.19M$14.18M$12.95M$12.49M$10.79M$10.49M$4.87M$14.15M$13.43M$11.96M
    Operating Income$-6,232,000$-5,692,000$-10,469,000$-8,380,000$-34,132,000$-6,020,000$-450,000$554,000$4.39M$-3,835,000$-3,074,000$875,000
    Interest Income$-338,000$1.26M$-221,000$-326,000$-198,000$-123,000$28,000$185,000$95,000$30,000$136,000$151,000
    Interest Expense$0$0$73,000$131,000$11,000$0$0$0$0$0$0$0
    Income Before Tax$-6,132,000$-4,163,000$-10,542,000$-8,511,000$-34,143,000$-5,982,000$-242,000$925,000$4.71M$-3,480,000$-2,645,000$1.28M
    Income Tax Expense$13,000$-102,000$11,000$9,000$9,000$5.66M$465,000$-1,401,000$958,000$1.54M$-618,000$565,000
    Net Income$-6,145,000$-4,061,000$-10,553,000$-8,520,000$-34,152,000$-11,644,000$-707,000$2.33M$3.75M$-5,016,000$-2,027,000$715,000
    EBITDA$-3,646,000$-2,992,000$-7,922,000$-5,907,000$-31,662,000$-3,785,000$1.32M$2.40M$6.34M$-1,615,000$-1,011,000$2.84M
    EBIT$-5,794,000$-5,419,000$-10,321,000$-8,185,000$-33,945,000$-5,859,000$-270,000$740,000$4.62M$-3,510,000$-2,781,000$1.13M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PETS

    News

    PetMeds (PETS) Q1 FY2027 Results Show Stabilizing Revenue but No Margin Relief Yet

    PetMeds (PETS) reported Q1 FY2027 results showing revenue stabilization but continued margin pressure, with net sales down 19.9% year-over-year to $41.0 million and adjusted EBITDA declining to negative $3.4 million. The company is implementing cost-cutting measures and an ERP system, and is pursuing a $37 million sale-leaseback of its headquarters to improve liquidity. Investors are also considering a non-binding takeover proposal from SilverCape Investments for $3.00 per share, adding a strategic dimension to the company's turnaround efforts.

    AlphaStreet•8/21/26•
    Bearish

    PetMed Express (PETS) Q1 2027 Earnings Call Transcript

    PetMed Express (PETS) reported Q1 2027 net sales of $41 million, a 19.9% decrease, but highlighted sequential revenue stabilization above $40 million and a narrowed net loss of $6.1 million. The company is focusing on strategic transformations, including a $37 million sale-leaseback agreement, a white-label pharmacy partnership with Rural King, and improved operational efficiencies, while actively evaluating an unsolicited acquisition proposal from Silver Cape Investments for $3 per share.

    The Globe and Mail•8/20/26•
    Neutral

    PetMed Express Q1 Earnings Miss Estimates, Sales Decline Y/Y

    PetMed Express (PETS) reported first-quarter fiscal 2027 results, missing Zacks Consensus Estimates for both top and bottom lines, with sales declining year-over-year. Despite the decline in sales and widened Adjusted EBITDA loss, the company narrowed its loss per share and focused on improving customer acquisition efficiency and expanding its reach through strategic partnerships like the one with Rural King. PetMed Express is also implementing financial, operational, and commercial improvements to drive sustainable profitability and shareholder value.

    TradingView•8/14/26•
    Somewhat-Bearish

    PetMed Express Q1 2027 Earnings Call Transcript

    PetMed Express (PETS) reported Q1 2027 earnings with a net loss of $6.1 million, significantly narrowed from $34.2 million year-over-year, despite a 19.9% decline in net sales to $41 million. The company focused on operational improvements, including a new white-label pharmacy partnership with Rural King, enhanced customer acquisition efficiency, and a sale-leaseback agreement for its headquarters to improve financial flexibility.

    MarketBeat•8/14/26•
    Somewhat-Bearish

    PetMed Express, Inc. Q1 2027 Earnings Call Summary

    PetMed Express (PETS) reported its Q1 2027 earnings, highlighting a strategic shift towards diversified customer acquisition, including B2B and white-label pharmacy offerings, after stabilizing revenue sequentially for three quarters. The company completed a major technology overhaul, reduced acquisition costs by 15%, and streamlined its cost structure, aiming for profitability. PetMed Express is also exploring growth initiatives like the Rural King co-branded pharmacy and considering an unsolicited acquisition proposal from Silver Cape Investments.

    Yahoo Finance•8/14/26•
    Somewhat-Bullish

    Frequently Asked Questions About PETS

    Does PETS pay dividends?
    PetMed Express Inc (PETS) has a dividend payment track record. See the PETS dividend history page for its current payment status, yield, and streaks.
    What is PETS's market cap?
    PetMed Express Inc (PETS) has a market capitalization of $40.97M with a current stock price of $1.89.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In